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Antiepileptic medications are the frontline treatment for seizure conditions. However,
these medications are not without cognitive side effects. Previously, our laboratory
reported learning deficits in phenytoin and carbamazepine-treated rats. In the experiment
reported here, the effects of valproic acid (VPA) have been studied using the same
instrumental training tasks. VPA-treated rats displayed a severe deficit in acquiring a
tone-signaled avoidance response. This deficit was attenuated in animals that had prior
training in an appetitive context. Thus, this deficit is specific to learning in an aversive
context, and does not result from difficulties in transferring associations from an appetitive
to aversive context. Learning transfer deficits were previously observed in rats treated
with phenytoin, and to a lesser extent, carbamazepine. On the other hand, rats treated
with VPA fail to suppress inappropriate responsiveness across aversive training whether
they had undergone prior appetitive training or not.
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INTRODUCTION
Epilepsy is a class of neurological disorders characterized by
reoccurring, unprovoked seizures (Chang and Lowenstein, 2003).
Population estimates suggest that 0.5–7.1 in 1000 people are
affected by epilepsy in any given year (Sander, 2003; Hirtz et al.,
2007). Pharmacological intervention with antiepileptic drugs
(AEDs) is the treatment of choice, but is not without cognitive
side effects in animal models (Banks et al., 1999, 2001; Churchill
et al., 2003; Samuelson et al., 2005; Umka et al., 2010) and human
patients (Loring and Meador, 2001; Meador et al., 2003; Hamed,
2009). Our laboratory has previously shown that phenytoin, a
commonly prescribed AED, blocked the acquisition of an avoid-
ance response in the second part of an instrumental appetitive-
to-aversive conditioning task (Banks et al., 1999). We have also
shown that carbamazepine, another commonly prescribed AED,
impairs the acquisition of an avoidance response and increases the
number of inappropriate responses in the second part of the same
appetitive-to-aversive conditioning task (Banks et al., 2001).
In the present study, we have extended our assessments to
valproic acid (VPA), as it too is very commonly employed in
treating seizure disorders. About 20% of epilepsy patients are
treated with VPA (Hsieh and Huang, 2011). VPA is the most
commonly prescribed AED in pediatric epilepsy cases, accounting
for almost 40% of AED prescriptions (Kwong et al., 2012). VPA is
also extensively used in the treatment of both manic and depres-
sive phases of bipolar disorder (Nasrallah et al., 2006), and is
considered a front-line treatment option for acute manic episodes
(Singh and Berk, 2008). Since VPA is used to treat a variety of
conditions, testing for side effects in healthy subjects is necessary
to produce results that are relevant to all users. Additionally,
testing in healthy subjects removes confounds arising from inter-
actions between disorders and medication (Meador et al., 1995).
Thus, any cognitive deficits observed with VPA treatment can
be attributed to the drug and not to any disorder, or drug-by-
disorder interaction.
The literature regarding the cognitive effects of VPA is mixed.
There are reports in the human clinical literature suggesting that
VPA exerts mild negative cognitive side effects. Patients treated
with 250 mg per day of VPA for 1 month showed performance
deficits relative to subjects treated with a placebo on delayed
recall, digit span, and serial addition tests (Meador et al., 1995).
Treatment with 1 g per day of VPA for 1 month also slowed
decision making when subjects were asked to categorize objects
by color or membership (Thompson and Trimble, 1981). Other
studies report more severe cognitive disturbances associated with
VPA treatment. One study reports severe cognitive dysfunction in
18 of 36 patients, accompanied by Parkinsonian symptoms such
as tremor and bradykinesis. Importantly, the majority of cognitive
and motor deficits were reversed upon termination of treatment
with VPA (Armon et al., 1996) suggesting that the dysfunctions
were associated directly with the drug and not with a neurological
disorder per se. VPA treatment has also been shown to exacerbate
cognitive decline when administered for HIV-related neuropathic
pain in late stage HIV (Cysique et al., 2006).
Some studies using animal models have also reported cognitive
side effects with VPA treatment, along with underlying neuro-
logical causes. Sub-chronic treatment with VPA increased the
amount of time rats spent exploring objects in familiar locations
on a novel object location test, suggesting a reduction in working
spatial memory. VPA treatment reduced cell proliferation in the
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subgranular zone of the hippocampal dentate gyrus in the same
rats (Umka et al., 2010). Treatment with 300 mg of VPA per kg
produced a decrease in accuracy in a rat spatial delayed non-
match-to-sample task when a delay of 4 s was used (Deacon,
1991). Cell proliferation in neuroblastoma and glioma cells have
also been shown to be decreased in the presence of VPA in the
therapeutic range (Regan, 1985).
Other studies, however, report an enhancement in the acqui-
sition, extinction, and reinstatement of cued conditioned fear.
Bredy and Barad (2008) report an increase in the freeze response
after conditioned stimulus (CS) presentation in VPA-treated rats
after 7 days of training. Moreover, VPA administration prior to
partial fear-extinction trials significantly decreased the freezing
response after 7 days of training in comparison to vehicle only
treated rats. Additionally, VPA administration enhanced the rein-
statement of conditioned fear 24 h after the presentation of a tone
and shock in animals who previously underwent fear extinction
conditioning. Enhancement of fear extinction was confirmed by
Heinrichs et al. (2013) using C57BL/6 mice. VPA had no effect on
extinction learning when a short duration CS was used, but sig-
nificantly reduced the freezing response when a longer duration
CS was used.
A few studies report improvements in performance on avoid-
ance tasks after treatment with VPA. Treatment with sodium
valproate improved the percentage of avoidance responses using
a shuttle-box paradigm, while treatment with magnesium VPA
had no effect. Only treatment with dipropylacetamide, a VPA
derivative, had a negative impact on performance (Continella
et al., 1984). Another study used a light/dark box in which rats
were placed in the illuminated portion of the box and subjected to
a foot-shock when entering the dark portion. Rats were adminis-
tered scopolamine, an anticholinergic agent, in the 6 h following
training. Scopolamine administration following avoidance train-
ing produces an amnesia-like effect. Treatment with pentyl-4-yn-
VPA 3 h after training reduced the amnesia effect of scopolamine
in a dose-dependent manner as demonstrated by longer latencies
for entering the dark portion of the box when tested 24 h later
(Murphy et al., 2001).
The amygdala has been found to underlie fear conditioning.
In one study, bilateral lesions were made in the rat amygdala or
dorsal hippocampus and underwent both cued and contextual
fear conditioning. Contextual fear conditioning is multimodal
and depends upon multiple background stimuli associated with a
specific location, while cued fear conditioning only depends on a
very discrete CS. Rats with lesioned amygdala failed to acquire the
conditioned fear response in both cued and contextual paradigms.
Rats with lesioned hippocampi showed no impairment in cued
fear conditioning, but exhibited decreased performance in con-
textual fear conditioning. The results indicate that the hippocam-
pus is involved in complex contextual fear conditioning, but not
simpler cued fear conditioning (Phillips and LeDoux, 1992).
In the present study, we have employed a within-subject, tone-
signaled bar press task in which rats are tested in both appetitive
and aversive contexts. The task employed is complex and multi-
contextual. There are multiple rules in the aversive context that
must be learned through conditioning. In the aversive context,
rats must learn to both press the lever after the tone, and not to
press the lever during the inter-trial period. This paradigm was
developed to study appetitive and aversive learning in the same
subjects, and has been used in past work to evaluate learning,
memory, and impairments that accompany cerebellar, hippocam-
pal, cingulate, and prefrontal cortex lesions (Steinmetz et al.,
1993; Logue, 1994). We have used this behavioral paradigm to
evaluate the effects of phenytoin and carbamazapine in adult rats
(Banks et al., 1999, 2001; McDowell et al., 2004), rats exposed
to phenytoin in utero (Mowery et al., 2008), rats with lesions of
the basal nucleus of Meynart (Butt et al., 2003), ovariectomized
female rats with or without estradiol replacement (Goodman
et al., 2004), and rats undergoing chronic restraint (McDowell
et al., 2013).
Although previous studies have shown VPA to enhance the
extinction of fear conditioning (Bredy and Barad, 2008; Heinrichs
et al., 2013) or performance on a simple avoidance task (Con-
tinella et al., 1984), they have also shown VPA to be detrimental to
spatial learning in association with decreased cellular proliferation
in the hippocampus (Umka et al., 2010). The complex nature of
the aversive task employed in this study would suggest that the
hippocampus facilitates task learning. Therefore, it is hypothe-
sized that VPA will interfere with the acquisition of the avoidance
response in the aversive context due to detrimental effects of VPA
on the hippocampus.
MATERIALS AND METHODS
Adult Sprague-Dawley rats bread in the Indiana University animal
care facilities were used. For comparison with previous studies
(Banks et al., 1999, 2001) and to exclude sex as a confounding
variable, only female rats were tested. In the literature, however,
there is no indication in that cognitive deficits associated with
AEDs are gender-linked as deficits are expressed in both males
and females (Meador et al., 1995). The estrus cycle was not
monitored as subject participation in the experiment extended
over roughly 60 days, and underwent multiple cycles. Any within-
subject variability possibly arising from hormonal fluctuations
would therefore be expected to be averaged out over the extended
training period.
The animals were maintained at 85% free-feeding body weight
throughout the study. The 45-mg food pellets used as appetitive
reinforcers (Bio-Serve, Frenchtown, NJ) were introduced to the
animals in the home cage at least 2 days prior to the beginning of
training. Animals were tested in an operant chamber (Lafayette)
placed in a lighted (10-W utility bulb) sound-attenuating cham-
ber, which contained a center-mounted speaker to deliver the tone
(2 kHz at 90 dB sound pressure level (SPL)). The front wall of the
operant box consisted of one bar at center and a recessed food well
on the left.
BACK WIRE IMPLANTATION
All animals underwent a simple surgical procedure to implant two
back wires, necessary as the connection point for the active lead
during the aversive component of the task, before beginning shap-
ing and training for the first (or only) component. Animals were
anesthetized with a mixture of ketamine and xylazine (60 and
6 mg/kg, respectively, intramuscular (IM)), with supplemental
doses given as needed. Two double-loop wires (30 gauge surgical),
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approximately 1 cm apart, were threaded subcutaneously between
the scapulae of each animal. Animals also received 0.2 cc Dopram
(IM) and triple antibiotic ointment on the area of the wires. The
entire procedure took approximately 15 min per subject.
DRUG ADMINISTRATION
VPA (Depakote; Sigma-Aldrich, St. Louis, MO) was administered
as stated in the detailed methods for each experimental condition.
The VPA oral suspension (125 mg/5 ml) was administered to each
animal via gavage twice daily. Oral administration was used in rats
in order to maintain consistency with the route of administration
most commonly used in humans. VPA treated animals received
150 mg of the drug per 1 kg body mass. One of the two daily
dosages was delivered 2 h before training. This regimen has been
previously shown to produce plasma levels within the human
therapeutic range during the training period (Churchill et al.,
2003).
APPETITIVE-TO-AVERSIVE TRANSFER TASK
Appetitive context
All sessions, appetitive or aversive, were separated by 24 h. In the
appetitive context, the animals were first shaped using a method
of successive approximations to bar-pressing behavior for food
reinforcement. When the animal pressed the bar 100 times in 30
min on a continuous reinforcement schedule, they were advanced
to a fixed-ratio reinforcement schedule (FR4) to strengthen the
behavior (i.e., render it more resistant to extinction). They were
then required to perform 400 bar presses (receiving 100 pellets)
within 30 min on two consecutive days before they began the tone
training trials.
During the tone-signaled sessions, only a response during the
tone period was reinforced. One session consisted of 100 tones,
each lasting 3 s or until the food pellet was delivered, followed
by a 15 s intertrial interval (ITI) and a randomly determined 1–
8 s pretone period. If the rats pressed the bar during the pretone
period, the period was reset and the trial was delayed until no
bar presses occurred during the randomly determined pretone
period. Animals continued appetitive tone training for a total of
31 days.
Aversive context
The rats were then transferred to a bar-press avoidance task. The
aversive context consisted of a shock that could be terminated
by a bar press. The shock intensity was usually maintained at
0.7 mA. If the animal did not respond to the shock level, it was
increased slightly until a level was found at which the animals
responded consistently, but never to exceed 1.0 mA. The animals
were introduced to the aversive context in a single training session
where the shock pulses were presented continuously until the bar
was pressed. If the animal did not press the bar, a rest period
of 30 s was initiated. Subjects were required to press the bar
prior to the onset of the fifth shock pulse at least 15–20 times
consecutively, and were advanced to tone trials on the next session
day. The tone was the same used in the appetitive conditioning
(2 kHz, 90 dB SPL). On tone-signaled trials, the impending foot
shocks could be avoided by a bar press during the first 3 s of
tone presentation, or escaped by a bar press in the latter 3 s after
the shock was initiated. The shock was delivered as a series of
four 250 ms pulses separated by 500 ms periods of no shock.
To prevent the animals from adopting a strategy of holding the
bar down for excessive amounts of time (thereby avoiding the
shock), continuous shock pulses were delivered if the animal
failed to release the bar after 5 s. These shocks are termed off-
bar shocks (OBS). The trials were separated by 8–12 s ITIs and
a variable 2–6 s pretone period. A bar press during the ITI or
pretone period reset the pretone period and delayed the initiation
of the next trial. One session of avoidance learning consisted of
300 tone presentations, or 300 chances to avoid or escape the
shock. The aversive phase of the experiment continued for 25
days.
EXPERIMENTAL CONDITIONS
Effects of VPA on appetitive-to-aversive transfer
Separate cohorts received treatment with VPA (N = 7) or water
only (N = 6) at the conclusion of the 21st day of appetitive
training. These animals continued appetitive tone training for 10
days to assess the effect of the drug and/or gavage procedure, if
any, on the acquired tone-signaled bar press. In addition, a third
cohort of rats served as controls (N = 12), receiving no gavage
treatment throughout the appetitive and avoidance training. After
initiation of drug or water treatment, behavioral testing began 2 h
after VPA or water administration. Drug or water administration
continued daily throughout the remaining appetitive and total
number of avoidance training sessions.
Effects of VPA on avoidance acquisition without prior appetitive
experience
Another group of animals were treated with VPA (N = 9) or water
(N = 10) treatment was initiated, and continued for 10 days,
at which time the animals began avoidance training. Animals
performed one session of aversive shaping and began the 25
days of tone-signaled avoidance training the following day. All
parameters in the aversive context remained as described above,
but without prior exposure to the appetitive context. An overview
of the two experimental conditions appears in Figure 1.
FIGURE 1 | Overview of experimental procedure. (A) One group of rats
underwent both appetitive and aversive conditioning. Drug administration
began 21 days into conditioning in the appetitive context. Both contexts
were proceeded by a brief period in which responses were shaped (S). (B)
A separate cohort of rats underwent conditioning in the aversive context
only. Drug treatment was initiated 11 days before the start of conditioning in
the aversive context.
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CALCULATIONS AND STATISTICS
In the appetitive context, the correct response rate (CR) is calcu-
lated as the percentage of reinforced bar presses out of the total
number of trials. In the aversive context, the CR is calculated
as the percentage of successful avoidance responses out of the
total number of trials. In both contexts, efficiency ratios (ERs) are
calculated by dividing the number of CRs by the total number of
bar presses. Percent positive transfer measures the impact of prior
appetitive experience on performance in the aversive context.
Percent positive transfer is calculated in terms of aversive CRs by:
100 × CRwith appetitive experience
CRwith appetitive experience
− 100
Percent positive transfer is also calculated in terms of aversive
ERs by replacing CRs with respective ERs. Positive values indi-
cate a beneficial effect of prior appetitive experience on aversive
performance while negative values indicate a detrimental effect of
prior appetitive experience on aversive performance.
To evaluate differences in performance between the drug-
treated and control groups across training days, a mixed-design
(split-plot) repeated-measure analysis of variance model was
applied (ANOVA). Statistical decisions were based on a 0.05
significance level. The calculations were carried out using SPSS
19.0 software, on a computer running Microsoft Windows 7.
RESULTS
VPA treatment had no impact on the performance in the appet-
itive context. Figure 2 presents percentages of reinforced bar
presses (CRs) and ERs (reinforced bar presses/total number of bar
presses) for VPA-treated and untreated controls. Water-treated
and untreated control groups have been collapsed together for
presentation because they did not differ for any of the training
days [F(1,16) = 2.203, p > 0.05]. As expected, during the first
5 days of training there were no statistically significant differ-
ences between the VPA-treated and control groups in terms of
CRs [F(1,17) = 1.092, p > 0.05], or ERs [F(1,17) = 0.212, p >
0.05]. After drug treatment was initiated at the conclusion of
the 21st day of training, performance remained indistinguish-
able between control and drug treatment groups. For the final
5 days of appetitive training, neither CRs [F(1,17) = 0.165, p >
0.05], nor ERs [F(1,17) = 0.086, p > 0.05], were significantly
different. Likewise, CRs, [F(1,17) = 1.419, p > 0.05] and ERs and
[F(1,17) = 0.151, p > 0.05] remained comparable over the entire
31 days course of appetitive training. Response latencies were also
measured for appetitive trials. As expected, the average response
latency of the group of rats treated with VPA remained stable
before initiation of drug treatment (924.6 ± 94.2 ms) and at the
conclusion of appetitive training [888.7 ± 76.8 ms; t(12) = 3.15,
p > 0.05].
Rats undergoing aversive conditioning without prior appeti-
tive experience were treated with VPA 10 days before the training
session began. VPA treatment significantly impaired acquisition
and expression of the avoidance response in the absence of appet-
itive experience (Figure 3). CRs for the entire 25 days training
period differed significantly for control and VPA-treated rats
[F(1,20) = 9.200, p < 0.05]. Likewise, ERs were also significantly
FIGURE 2 | Appetitive percent reinforced responses (top) and efficiency
ratios (bottom) for control and VPA treated animals are displayed.
Percentage of reinforced bar presses correct response rates (%CRs) and
efficiency ratios (ERs) for control animals demonstrate that these animals
learn the appetitive task. Arrow denotes beginning of drug treatment. Since
drug treatment was initiated on the 21st day of appetitive training, any
difference in acquisition on days 1–20 is due to individual differences.
Valproic acid (VPA)-treated animals show no negative effect on the
maintenance of appetitive performance. Error bars display the standard
error of the mean.
different [F(1,20) = 13.825, p< 0.05]. VPA-treated animals showed
severe deficits in both the acquisition and terminal expression of
the avoidance response. During acquisition (days 1–5), control
animals exhibited a daily average CR of 45.5% while VPA-treated
animals exhibited an average CR of only 9.4%. Terminal expres-
sion (days 21–25) of the avoidance response was also negatively
affected by VPA, with controls exhibiting an average CR of 60.4%
while VPA treated animals only exhibited an average CR of 37.4%.
Lower ERs for VPA-treated rats indicates that their bar pressing
behavior is more random than controls.
Prior appetitive experience attenuated performance deficits in
VPA-treated rats. Figure 4 presents CRs and ERs for the entire
course of avoidance training for VPA-treated and control rats.
Water-treated and untreated controls were again collapsed in this
figure since avoidance performance is comparable between these
two groups in terms of both CRs [F(1,15) = 0.003, p > 0.05]
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FIGURE 3 | Aversive percent avoidances responses (top) and efficiency
ratios (bottom) for control and VPA treated animals, without prior
training in the appetitive context, are displayed. VPA-treated animals
displayed drastically reduced acquisition and expression of the avoidance
response, in comparison to control animals. Prior experience in an
appetitive context was advantageous for VPA-treated animals, but had not
effect for controls. Error bars display the standard error of the mean.
and ERs [F(1,15) = 0.002, p > 0.05]. VPA treatment had no
significant effect on appetitive to aversive transfer as CRs over the
25 days of training were not statistically different [F(1,17) = 0.402,
p > 0.05]. Similarly, control and VPA-treated ERs were also not
statistically different from each other when compared across the
entire training period [F(1,17) = 0.997, p > 0.05].
Aversive learning in VPA-treated animals varied substantially
depending on whether there had been prior appetitive training.
To further underscore this difference, avoidance learning behav-
ior was compared directly in the presence or absence of prior
appetitive experience. The daily average avoidance rate over the
first 5 days of training for the VPA-treated animals with prior
appetitive training was 26.9% as compared to just 9.4% for the
animals that had no previous appetitive training. Over the last 5
days of training, the daily average avoidance rates were 63.6% and
37.4% respectively for the VPA-treated rats with or without prior
appetitive training. Comparing performance across the entire
training period, the two groups differed significantly [F(1,14) =
6.444, p < 0.05]. A similar pattern is present for the ERs. Over
the first 5 days of training, the daily average ER for the animals
with prior appetitive experience was 0.080 as compared to 0.031
FIGURE 4 | Aversive CRs (top) and ERs (bottom) for control and VPA
treated animals, following training in the appetitive context, are
displayed. Although the acquisition of the avoidance response appears to
be delayed in VPA-treated animals, differences were found to be statistically
insignificant (see text). The terminal expression of avoidance behavior for
both groups is comparable, demonstrating that VPA did not significantly
affect appetitive-to-aversive transfer. Error bars display the standard error of
the mean.
for those without. Over the last 5 days of training the averages
were 0.359 and 0.158 respectively. A repeated measures ANOVA
comparing performance across all training days found the two
groups to differ significantly [F(1,14) = 7.940, p< 0.05].
The percent positive transfer for CRs and ERs of animals
with prior appetitive experience as compared to animals placed
directly into the aversive context is presented in Figure 5. Con-
trol animals performed similarly in the presence or absence of
prior appetitive experience. VPA-treated animals, on the other
hand, profited substantially from appetitive training prior to
the avoidance learning challenge. This high degree of learn-
ing transfer from the appetitive to aversive context underscores
the remarkably important contribution of appetitive training
to avoidance learning in VPA-treated animals. The figure also
illustrates that the performance deficit observed when placed
directly into the aversive learning context does not reflect a
drug-related problem with avoidance learning per se. The deficit
is more nuanced as VPA-treated rats with prior appetitive
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FIGURE 5 | Percent positive transfer (prior appetitive experience
relative to aversive experience only) based upon percent avoidance
response (top) and ERs (bottom) for control and VPA-treated animals.
Prior appetitive experience greatly enhanced both avoidance rates and ERs
for VPA-treated animals. Interestingly, prior appetitive experience did not
affect the performance of drug-naïve animals in either direction. Error bars
display the standard error of the mean.
experience performed sufficiently well in the aversive context
such that performance was not significantly different from
controls.
OBS are applied when an animal fails to release the bar after
5 s in the aversive context and are a measure of inappropriate
responses. VPA-treated animals with prior appetitive experience
received an average of 275 OBS while controls only received
198 (Figure 6, top). The difference is more striking for the
final 5 days of training were VPA-treated animals still received
an average of 192 OBS while control animals only received an
average of 50. A mixed-design repeated measures ANOVA across
all 25 training days revealed the difference in OBS received to
be significant [F(1,20) = 8.853, p < 0.01]. VPA-treated animals
lacking prior appetitive experience also incurred substantially
more OBS than control animals (Figure 6, bottom). During
the first 5 training days, both VPA-treated and control animals
experienced more OBS on average than their counterparts who
had appetitive training, with the groups receiving on average 348
and 252 OBS respectively. During the final 5 training days, control
animals reduced the average number of OBS received to 39 while
FIGURE 6 | The average number of off-bar shocks (OBS) received
during an aversive training session for rats exposed to both the
appetitive and aversive contexts (top) and those exposed to the
aversive context only (bottom). Repeated measures ANOVA
demonstrated the difference to be significant across all 25 individual
training days. In both cases, VPA-treated animals failed to suppress the
primitive response of pressing and holding the bar, while controls
abandoned this strategy in the first 5 training sessions. Error bars display
the standard error of the mean.
VPA treated animals received an average of 149. The difference
across all 25 training days was found to be statistically significant
[F(1, 20) = 4.520, p< 0.05].
DISCUSSION
Conflicting reports of cognitive deficits in patients maintained on
AEDs have motivated our ongoing evaluation of these drugs using
a variety of behavioral paradigms (Churchill et al., 1998, 2003;
Banks et al., 1999, 2001; McDowell et al., 2004; Samuelson et al.,
2005). The present study expands our efforts to VPA, using the
same well-defined instrumental learning and memory paradigm
used to investigate phenytoin and carbamazepine in previous
studies. The results demonstrate drug-specific cognitive deficits,
with VPA inhibiting the acquisition of the avoidance response
in the absence of prior appetitive training. Unlike our previous
study where phenytoin impaired the transfer between appeti-
tive and aversive contexts (Banks et al., 1999), prior appetitive
training enhanced acquisition of the avoidance response in VPA-
treated animals relative to animals placed directly into the aversive
learning context.
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VPA treatment had no apparent effect on the animals’ already-
acquired appetitive performance. VPA treatment was initiated
on the 21st day of appetitive conditioning and maintained
throughout the remaining appetitive and aversive training. We
find no differences in appetitive performance of the VPA-treated
animals when comparing pre- (training days 16–21) to post-drug
(training days 26–31) data, with both reinforced responses and
ERs remaining stable and comparable to controls (Figure 2).
Response latencies were shown to remain stable between the
initiation of drug and the conclusion of appetitive training.
The effects of VPA on instrumental performance are not likely
attributable to sensorimotor disruptions. A slowing of sensory
processing of the cue stimulus and/or response production could
generate an apparent avoidance learning deficit if the animal
was not able to produce the response within the initial 3 s
tone period. The absence of any response latency difference
following the onset of drug treatment clearly suggests that
neither of these performance factors suffered from the drug
treatment.
VPA treatment diminished aversive performance in rats with-
out prior appetitive experience. Whereas control animals reached
asymptotic performance within the first 10 days of training, the
performance of VPA-treated animals was substantially reduced
throughout training (Figure 3). An even greater difference is
observed in terminal ERs. Over the last 5 days of avoidance
training, the VPA-treated animals were making in excess of 7.5
bar presses for each successful avoidance, whereas control animals
were making less than 3 bar presses per avoidance. While control
animals did produce fewer bar presses than VPA-treated animals
on average (557 and 878 bar presses per session, respectively,
across the last 5 days of training), this difference is not large
enough to fully account for the difference in ERs. Rather, the
control animals were clearly distributing their responses more
appropriately with respect to the tone signal than were the drug-
treated animals.
Prior appetitive experience attenuated aversive performance
deficits in VPA-treated rats. Following the conclusion of appeti-
tive training, the rats were transferred to an aversive context in
which an aversive stimulus could be actively avoided with a tone-
signaled bar press (Figure 4). At first appearance, VPA-treated
animals appear to have a slight delay in avoidance acquisi-
tion, with terminal performance reaching levels comparable to
controls. However, a repeated measures ANOVA failed to reveal
any significant difference between the average CRs or ERs for
VPA-treated and control animals for the entire course of training.
Any possible performance difference between VPA-treated and
control animals is relatively mild and diminishes early in training,
at least in terms of CRs and ERs.
OBS are administered to animals that maintain a sustained bar
press irrespective of the stimulus conditions. Behavior resulting
in OBS can be characterized as “primitive” avoidance responses,
indicating the learning of some fundamental relationship between
the bar presses and shock cessation. Regardless of prior appet-
itive experience, VPA-treated animals experienced more OBSs
throughout the 25 days aversive context, suggesting some degree
of cognitive impairment. Both control and VPA-treated animals
begin aversive training with a relatively high number of OBS.
By the end of the 25 days of training, control animals have
generally learned to suppress this primitive response while VPA-
treated animals show relatively little decline in this inappropriate
and ultimately ineffectual behavior. The larger number of OBS
received by VPA-treated animals during all 25 days of the aversive-
only context contributed to lower ERs. Even in the absence of
prior appetitive training, control animals learned to suppress the
primitive avoidance response while VPA-treated animals failed
to appropriately distribute bar presses (Figure 6, bottom). This
failure of VPA-treated animals represents a learning deficit in an
aversive context, regardless of prior appetitive experience.
In the aversive condition, rats must learn at least two rules:
press the bar directly after the tone/light signal, and avoid pressing
the bar during the ITI. Failure to follow either one of these rules
results in electrical shock. Moreover, the former rule requires
pressing the lever while the later rule requires not pressing the
lever. Difficulty in lever pressing and avoiding electrical shocks
may arise due to the complexity of the task. It is possible that
learning multiple tasks in the aversive context was undermined
by VPA. The high rate of OBS received by both groups of VPA-
treated animals indicates that neither group fully learned not to
press the bar in the ITI and avoid the resulting OBS. Apparently
without the benefit of appetitive training, VPA-treated animals
also failed to fully learn the tone/light signal and response of
pressing the bar to avoid electrical shock. Nonetheless, both
control animals and VPA-treated animals that had the benefit of
appetitive experience managed to avoid the tone/light signaled
shocks at a greater frequency that did VPA-treated animals lacking
appetitive experience.
VPA has been shown to strengthen fear-conditioning (Bredy
and Barad, 2008), extinction of conditioned fear (Bredy and
Barad, 2008; Heinrichs et al., 2013), and reinstatement of cue-
induced appetitive operant conditioning (Ploense et al., 2013).
VPA decreases cellular proliferation while putatively promoting
cellular transcription through preventing chromatin compacting
associated with deacetylation of lysine residues (Phiel et al.,
2001). Different memory mechanisms are involved in Pavlo-
vian conditioning, cue-induced fear-conditioning, and contex-
tual fear-conditioning. Cue-induced fear-conditioning requires
activation of the amygdala. Context-induced fear conditioning,
however, requires activation of both the amygdala and the hip-
pocampus (Phillips and LeDoux, 1992). Inhibiting hippocampal
adult neurogenesis has been shown to impair acquisition of a
conditioned-fear response using a trace conditioning paradigm,
a hippocampal-dependent task (Shors et al., 2002). VPA has
been previously shown to inhibit hippocampal neurogenesis
(Umka et al., 2010). Perhaps this effect of VPA is detrimental
to acquiring the avoidance response without prior appetitive
experience.
As with VPA, we have previously reported that treatment
with phenytoin did not affect the maintenance of the appetitive
response. In contrast to VPA, phenytoin-treated animals did not
display an avoidance learning deficit when placed directly into
the aversive context. In the absence of prior appetitive experi-
ence, phenytoin-treated animals performed as well as controls
in terms of CRs and ERs. Also in contrast to VPA-treated rats,
prior appetitive experience had a detrimental effect on avoidance
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acquisition in phenytoin-treated animals. In these animals, prior
appetitive experience interfered with learning. Phenytoin-treated
animals consistently displayed CRs of 20% or less and ERs of 0.1
or less across all 25 training days in the presence of prior appetitive
training (Banks et al., 1999).
As with VPA and phenytoin, carbamazepine also failed to
affect the maintenance of the appetitive response (Banks et al.,
2001). Carbamazepine increased the variability of CR and ER
performance, compared to controls, suggesting that the effects
of carbamazepine vary greatly within groups. Carbamazepine-
treated animals also failed to suppress the primitive avoidance
response, leading to numbers of OBS comparable to VPA treated
animals following appetitive training. Unlike VPA-treated ani-
mals, however, no differences were observed between carba-
mazepine treated animals and controls is the absence of prior
appetitive training (Banks et al., 2001). Thus, carbamazepine
causes a slight impairment in learning transfer from appetitive to
aversive learning, while VPA does not.
A major limitation of this study is the sole reliance on
behavioral data and lack of neurological evidence. Although other
studies report that VPA decreases hippocampal adult neurogene-
sis (Umka et al., 2010), effects of VPA on hippocampal neuronal
proliferation were not directly tested in this study. Future studies
on the cognitive effects of VPA should compare cue-induced with
contextual fear conditioning, and utilize histological methods
in addition to behavioral methods. Moreover, additional work
remains to be performed in order to delineate VPA impairment of
acquisition of the tone-barpress association from its expression.
This could be suitably studied by initiating drug treatment 11
days into the aversive context, by which time the tone-barpress
associated would have already been acquired.
The three first-generation AEDs studied thus far show
different types and severities of cognitive impairment. Pheny-
toin is associated with severe impairment in the transfer of
learning from the appetitive to aversive context, to the point
where prior appetitive experience interferes with acquisition of
even the primitive avoidance response. However phenytoin does
not affect learning in an aversive context per se as phenytoin-
treated animals lacking prior appetitive experience display no
performance deficits (Banks et al., 1999). The detrimental effects
of carbamazepine seem to be a milder impairment than that
observed with phenytoin treatment. Carbamazepine-treated ani-
mals readily acquired the primitive avoidance response, but failed
to suppress it following appetitive training. Since this deficit
was not observed in the absence of prior appetitive training,
it is also not a learning deficit in aversive context per se, but
indicates impairment in learning transfer as well (Banks et al.,
2001).
Cognitive impairment associated with VPA is fundamen-
tally different from phenytoin or carbamazepine. Prior appeti-
tive experience greatly facilitated the acquisition of the proper
avoidance response, to the extent that CRs and ERs are not
significantly different from control animals. However, the larger
number of OBS suggests that VPA-treated animals were not nearly
as capable of suppressing this response as control animals. In
the absence of prior appetitive training, significantly different
CRs and ERs, in addition to a greater number of incurred OBS,
demonstrate impaired learning in aversive contexts. Presumably,
second-generation AEDs will provide greater efficacy with less
detrimental side effects. Future research will extend our analysis
to these drugs using the same learning transfer paradigm.
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